Abstract
It was always been a matter of great-controversy regarding the dosage protocol of anti- snake venom (ASV) in the management of snake envenomation. The only definitive treatment of poisonous snake bite is ASV administration. MATERIAL AND METHODS: This study was carried out for a period of two years. All patients of neuroparaplytic snake bite who presented to the emergency department were included in this prospectively study. RESULTS: Fifty eight patients of neurotoxic snake bite became eligible for the study over a period of 2 yrs. By using chi-square test, the outcomes in low and high bolus dose group were statistically non-significant (P>0.05). Statistical analysis showed no significant difference in both groups. From this study it can be firmly concluded that low dose ASV is as effective as high dose in treatment of neurotoxic snake bite.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
